These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 1791323

  • 21. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM, LAIV Study Group.
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [Abstract] [Full Text] [Related]

  • 22. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.
    Feldman AG, Beaty BL, Ferrolino JA, Maron G, Weidner HK, Ali SA, Bitterfeld L, Boulware MA, Campbell KM, Carr E, Chapman S, Chang YC, Cunningham R, Dallas RH, Dantuluri KL, Domenick BN, Ebel NH, Elisofon S, Fawaz R, Foca M, Gans HA, Gopalareddy VV, Gu C, Gupta NA, Harmann K, Hollenbeck J, Huppler AR, Jaramillo C, Kasi N, Kerkar N, Lerret S, Lobritto SJ, Lopez MJ, Marini E, Mavis A, Mehra S, Moats L, Mohandas S, Munoz FM, Mysore KR, Onsan C, Ovchinsky N, Perkins K, Postma S, Pratscher L, Rand EB, Rowe RK, Schultz D, Sear K, Sell ML, Sharma T, Stoll J, Vang M, Villarin D, Weaver C, Wood P, Woodford-Berry O, Yanni G, Danziger-Isakov LA.
    JAMA Netw Open; 2023 Oct 02; 6(10):e2337602. PubMed ID: 37824141
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul 02; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
    Ehrenkranz NJ, Ventura AK, Medler EM, Jackson JE, Kenny MT.
    Bull World Health Organ; 1975 Jul 02; 52(1):81-5. PubMed ID: 764997
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 32. Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.
    Scott LJ.
    Paediatr Drugs; 2015 Apr 24; 17(2):167-74. PubMed ID: 25732634
    [Abstract] [Full Text] [Related]

  • 33. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA, Novelli VM, Lipton SV, Pollock B.
    Pediatrics; 1988 Jun 24; 81(6):779-84. PubMed ID: 2835743
    [Abstract] [Full Text] [Related]

  • 34. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S, Doerr HW, Allwinn R.
    Dtsch Med Wochenschr; 2001 Nov 16; 126(46):1289-93. PubMed ID: 11709730
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC, Burgess MA, O'Brien ED.
    Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551
    [No Abstract] [Full Text] [Related]

  • 37. [Vaccination against rubella, measles, chickenpox, and mumps in nursing students].
    Tashiro T, Urata H, Okada J, Iwanaga K, Tokunaga M, Matsumoto T.
    Kansenshogaku Zasshi; 2004 May 06; 78(5):398-403. PubMed ID: 15211861
    [Abstract] [Full Text] [Related]

  • 38. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ, Li Q, Yan R, Zhou Y, Tang XW, Deng X, Xie SY, Chen ZP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr 06; 51(4):336-340. PubMed ID: 28395468
    [Abstract] [Full Text] [Related]

  • 39. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 06; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 40. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE, Buynak EB, McLean AA, Hilleman MR.
    Pediatrics; 1978 Jan 06; 61(1):5-11. PubMed ID: 263873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.